ONDCP at Rx Summit: Hydrazine an emerging health threat.

HEALTH policy; COMBINATION drug therapy; HETEROCYCLIC compounds; CONFERENCES & conventions; PUBLIC health; FENTANYL; GOVERNMENT agencies; TELEMEDICINE

This year's Rx and Illicit Drug Summit drew 4,000 participants to the Georgia World Congress Center in Atlanta last week; there were 100 exhibitors, and the pparticipants included ounselors, social workers, therapists, psychologists, and interventionists; physicians, psychiatrists, nurses, pharmacists, and dentists; advocates, families, and people in recovery; law enforcement and other first responders; state and federal lawmakers; and public health and prevention professionals. ADAW was able to pick up many new stories and meet with old friends and colleagues. The conference was also the setting for an announcement about a new emerging threat — fentanyl combined with xylazine (https://onlinelibrary.wiley.com/doi/10.1002/adaw.33205). [ABSTRACT FROM AUTHOR]

Copyright of Alcoholism & Drug Abuse Weekly is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)